Skip to content

Cardiometabolic Care-team Integration Improves Outcomes in Diabetes

Cardiometabolic Care-team Integration in Primary Care Improves Outcomes in Diabetes: a Pragmatic, Case-controlled Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03561714
Enrollment
475
Registered
2018-06-19
Start date
2012-03-01
Completion date
2014-12-30
Last updated
2022-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardio-metabolic Care-Team Intervention (CMC-TI)

Brief summary

A pragmatic, quasi-experimental (non-randomized) design was used to evaluate clinical and cost outcomes among patients with type 1 or 2 diabetes (T1D or T2D) at two primary care clinics (n=1 intervention, n=1 usual care) between March 2012 and September 2014. At the intervention clinic, the 12-month Cardio-metabolic Care-Team Intervention (CMC-TI) was delivered to all qualifying patients; surveys were administered to evaluate relevant patient-reported outcomes over 12 months, and a process evaluation gauged CMC-TI feasibility and satisfaction.

Interventions

BEHAVIORALCardometabolic Team Intervention

The CMC-TI team included a registered nurse/certified diabetes educator (RN/CDE) Care Manager, medical assistant (MA) Health Coach, and RN Depression Care Manager. Decision support tools guided therapy for glucose, BP, low-density lipoprotein cholesterol (LDL-c), and depression. At the intervention clinic, the 12-month CMC-TI was delivered to all qualifying patients; surveys were administered to evaluate relevant patient-reported outcomes over 12 months.

Sponsors

Scripps Whittier Diabetes Institute
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All patients with type 1 and type 2 diabetes

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
HbA1c12 monthsChange in HbA1c between Intervention and Comparator sites

Secondary

MeasureTime frameDescription
Hospital/ER costs12 months
LDL12 monthsChange in LDL between Intervention and Comparator sites
Blood pressure12 monthsChange in blood pressure between Intervention and Comparator sites

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026